The New York Office of Cannabis Management Publishes Educational Fact Sheet on Cannabis and Fentanyl
To address misinformation surrounding fentanyl and cannabis, the New York Office of Cannabis Management published a fact sheet.
In October 2023, the New York Office of Cannabis Management (OCM) published “Cannabis and Fentanyl: Facts and Unknowns,” in the Educational Materials section of their website (1,2). Legislation legalizing adult-use cannabis in the state was signed into law in March 2021 and the OCM, governed by the Cannabis Control Board, was created to regulate cannabis, including issuing licenses (2). Medical cannabis had already been legal in the state before 2021 (2).
The fact sheet defined fentanyl and explained that it is becoming increasingly common in unregulated drug supplies (1). “Warnings related to fentanyl ‘contamination’ in cannabis have increased as states continue to legalize cannabis,” the fact sheet also stated (1). “At this time, there have been zero verified incidents of fentanyl ‘contamination’ in cannabis. There is no guarantee that any unregulated cannabis product is free from contaminants or harmful ingredients.”
The purpose of the two-page sheet is to (1) “address misconceptions about cannabis being mixed with fentanyl. The goal of this fact sheet is to provide evidence where it is available, to share information about what is currently known and unknown, and to provide safety tips to help alleviate some of these misconceptions, often spread through misinformed media coverage and anecdotal reporting.” It included key findings, explained ways to reduce the stigma around opioid overdoses, and provided safety recommendations for cannabis users (1).
Some of the key findings included (2):
- Misinformation continues to be widespread about the dangers of accidentally overdosing on cannabis “contaminated” with fentanyl.
- Anecdotal accounts of cannabis “contaminated” by fentanyl have been found to be false at the time of publication.
- Reliable testing protocols for detecting fentanyl on cannabis flower are still unknown.
The OCM recommended that cannabis users buy products from licensed stores to ensure they are laboratory tested for contaminants, and cautioned that products from unregulated supplies can be untested or improperly labelled (1).
References
- Cannabis and fentanyl: Facts and unknowns https://cannabis.ny.gov/system/files/documents/2023/10/ocm_cannabisandfentanyl.pdf (accessed Nov 8, 2023).
- Marihuana regulation and taxation act (MRTA) https://cannabis.ny.gov/marihuana-regulation-and-taxation-act-mrta (accessed Nov 7, 2023).
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
